October 20, 2016 3:44 PM ET


Company Overview of Histogen, Inc.

Company Overview

Histogen, Inc., a regenerative medicine company, develops therapies based upon the products of cells grown under simulated embryonic conditions. The company focuses on the research, development, and manufacturing of products derived from its technology. It offers an insoluble human extracellular matrix (hECM); and a soluble complex of proteins. The company’s technology focuses on stimulating a patient's own stem cells by delivering a complex of multipotent human proteins that support stem cell growth and differentiation. It has joint venture with PUR Biologics, Adaptive Biologix, and Histogen Aesthetics to develop additional products. Histogen, Inc. was founded in 2007 and is based in San Di...

10655 Sorrento Valley Road

San Diego, CA 92121

United States

Founded in 2007





Key Executives for Histogen, Inc.

Founder, Chairman and Chief Executive Officer
Age: 60
Executive Director
Director of Corporate Communications
Director of Clinical Affairs
Director of Applied Research
Compensation as of Fiscal Year 2016.

Histogen, Inc. Key Developments

Histogen, Inc. Announces License Agreement with Pineworld Capital, Ltd., for Development and Commercialization of its Proprietary Hair Stimulating Complex (HSC) in Mainland China

Histogen, Inc. announced a license agreement with Pineworld Capital Ltd., for the development and commercialization of its proprietary Hair Stimulating Complex (HSC) in Mainland China. Through an exclusive license and supply agreement, Pineworld will focus on clinical development, registration, marketing and sales of the HSC injectable hair growth treatment in China. Under the terms of the license, Histogen will receive the payments, a transfer price on the product, and escalating royalties on future sales. Histogen will utilize its patented technology process to manufacture HSC for the China market.

Histogen to Enter into Licensing Agreement with Huapont Life Sciences

Histogen, Inc. and Huapont Life Sciences Co., Ltd. are planning to enter into a license and supply agreement for the development and commercialization of hair stimulating complex (HSC) product in Mainland China. Histogen is a US-based regenerative medicine company that develops solutions based on the products of cells grown under simulated embryonic conditions, while Huapont Life Sciences is a China-based pharmaceutical company.

Histogen, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015

Histogen, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Private Placement
August 10, 2016

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Histogen, Inc., please visit www.histogeninc.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.